Page 8 - Bharat Biotech

Top Headlines: Paytm ups IPO size to Rs 18,300 cr, no nod for Covaxin yet

Business Standard brings you the top headlines at this hour

No nod for Bharat Bio's Covaxin yet, WHO seeks 'additional clarifications'

The technical advisory group will now meet on November 3 for a final assessment.

Review of Covaxin underway, expect a recommendation within 24 hours: WHO

A technical advisory group of the WHO reviewing data on Covaxin for the emergency use listing of India's vaccine and if it is satisfied a recommendation is expected within the next 24 hours or so

Vaccine makers meet WTO D-G, flag excess capacity of Covid-19 jabs

Some manufacturers also said that the regulatory approval framework for Covid-19 vaccines in other nations also takes a substantial amount of time

WHO chief, Mandaviya talk Covaxin, resuming Covishield supply to COVAX

WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech's COVID-19 vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya. Had a call with @mansukhmandviya, India's Health Minister, to discuss #India's ongoing #COVID19 vaccination programme; the need for a global pandemic agreement; digital health; & traditional medicine. We welcome India's support to strengthen WHO, incl. via flexible, sustainable financing, Ghebreyesus tweeted on Tuesday. The WHO Director-General said that he also discussed with Mandaviya vaccine equity issues: the resumption of SII/AstraZeneca vaccine supplies to #COVAX; the Covaxin Emergency Use Listing process; and technology and license sharing through C-TAP. COVID-19 Technology Access Pool (C-TAP) was launched in May last year for facilitating ...

Top headlines: Govt plans IDBI sale; chief economist Gopinath to leave IMF

India's drug regulator is examining recommendation by experts for approving Bharat Biotech's Covaxin for children. More in top headlines this morning.

Bharat Biotech's Covaxin roll-out for children likely in phases

Vaccine performance, availability being evaluated

Long wait: Vaccine makers queue up for WHO approval, shows data

Industry insiders say typically a WHO EUL takes between two months and a year

WHO expecting more info from Bharat Biotech for Covaxin approval

Covaxin is one of the three approved vaccines that have been used in India for the country's vaccination drive for adults.

Top headlines: NCLT setback for Amazon; WHO seeks more info for Covaxin

Business Standard brings you the top stories from today

WHO's technical group to meet on Oct 26 to consider EUL of Covaxin

The WHO experts are currently reviewing this information and if it addresses all questions raised, the WHO assessment will be finalised next week

Bharat Biotech's Covaxin gets expert panel's nod for children above 2 years

First Covid-19 vaccine in the world for children this young

Awaiting regulatory nod to launch Covaxin for children: Bharat Biotech

The expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain conditions.

Bharat Biotech submits clinical trial data for paediatric vaccine to DCGI

The vaccine maker added that Covaxin is the first Covid-19 vaccine to be tested in the 2-6-year age group

WHO technical advisory group to take call on Covaxin EUL next week

Vaccine maker presented data before SAGE working group on Tuesday

Scientists' body expresses concern over WHO not granting EUL for Covaxin

A national network of scientists, AIPSN, has expressed concern over the World Health Organisation not granting emergency use listing for ICMR-Bharat Biotech's Covaxin.

Decision on Bharat Biotech's Covaxin EUL in October, says WHO

A decision on Bharat Biotech's submission seeking emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October, the World Health Organisation has said

Diligently working with WHO to obtain EUL for Covaxin: Bharat Biotech

The vaccine maker said it will make on announcement to indicate the availability of regulatory approval at an appropriate time

Top headlines: PM Modi reaches New York, FinMin withdraws spending curbs

Business Standard brings you the top headlines on Saturday

Booster dose: Bharat Biotech's nasal vaccine may be used with Covaxin

The idea is to see which combination induces better and long-lasting immune response